PubMed Health⌕ Search

PubMed · 9179643

What can we achieve by implementing a compliance-improvement program?

Abstract

Efforts to improve compliance and facilitate other aspects of relapse-prevention strategies can have a profound impact on the lives of millions of people around the world as well as conserving precious health-care dollars. Simultaneous efforts to educate patients and families on the nature of the disease, its course and optimum treatment, together with efforts to educate physicians and other health-care professionals on the indications, benefits and risks of long-term treatment, are critical for improving the current state of affairs. In addition, it is imperative to educate the public at large and particularly those health-care administrators and public servants who control or influence the allocation of the resources needed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Kane. 1997. What can we achieve by implementing a compliance-improvement program?. https://doi.org/10.1097/00004850-199702001-00007

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Differential pharmacology of atypical antipsychotics: clinical implications.

PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.

Antipsychotic Agents↗